{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:30:12Z","timestamp":1791397812868,"version":"4.3.3"},"reference-count":194,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Italian MIUR FIRB","award":["RBAP10447J_003"],"award-info":[{"award-number":["RBAP10447J_003"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.bbamcr.2014.09.023","type":"journal-article","created":{"date-parts":[[2014,10,4]],"date-time":"2014-10-04T10:57:01Z","timestamp":1412420221000},"page":"14-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Autophagy in acute leukemias: A double-edged sword with important therapeutic implications"],"prefix":"10.1016","volume":"1853","author":[{"given":"Cecilia","family":"Evangelisti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Evangelisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Chiarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Lonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Buontempo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca M.","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"McCubrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M.","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2014.09.023_bb0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4161\/auto.4377","article-title":"How shall I eat thee?","volume":"3","author":"Klionsky","year":"2007","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0010","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00018-011-0865-5","article-title":"Microautophagy: lesser-known self-eating","volume":"69","author":"Li","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/cr.2013.153","article-title":"Chaperone-mediated autophagy: roles in disease and aging","volume":"24","author":"Cuervo","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4093\/dmj.2013.37.5.333","article-title":"The interplay between autophagy and aging","volume":"37","author":"Pyo","year":"2013","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0025","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.febslet.2014.06.015","article-title":"Regulation of autophagy: modulation of the size and number of autophagosomes","volume":"588","author":"Jin","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0030","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.yexcr.2013.01.018","article-title":"High glucose induces autophagy in podocytes","volume":"319","author":"Ma","year":"2013","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0035","article-title":"Endoplasmic reticulum stress and protein quality control in diabetic cardiomyopathy","author":"Yang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0040","article-title":"Autophagy and oxidative stress in cardiovascular diseases","author":"Mei","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0045","article-title":"Autophagy: a housekeeper in cardiorenal metabolic health and disease","author":"Jia","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cell.2014.02.049","article-title":"To be or not to be? How selective autophagy and cell death govern cell fate","volume":"157","author":"Green","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0055","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0060","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ncb0910-814","article-title":"Eaten alive: a history of macroautophagy","volume":"12","author":"Yang","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature09782","article-title":"Autophagy in immunity and inflammation","volume":"469","author":"Levine","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0070","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbadis.2008.06.010","article-title":"Autophagy in neurodegeneration and development","volume":"1782","author":"Winslow","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0075","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0080","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/ncb2788","article-title":"Emerging regulation and functions of autophagy","volume":"15","author":"Boya","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ceb.2014.02.005","article-title":"The protein-vesicle network of autophagy","volume":"29C","author":"Ge","year":"2014","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0090","article-title":"Therapeutic targeting of autophagy in cancer. Part I: molecular pathways controlling autophagy","author":"Nagelkerke","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0095","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nrm2708","article-title":"Dynamics and diversity in autophagy mechanisms: lessons from yeast","volume":"10","author":"Nakatogawa","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/cdd.2011.146","article-title":"Cell death by autophagy: facts and apparent artefacts","volume":"19","author":"Denton","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0110","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ceb.2009.11.014","article-title":"Mammalian autophagy: core molecular machinery and signaling regulation","volume":"22","author":"Yang","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0115","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cellsig.2009.01.004","article-title":"Akt-dependent and -independent mechanisms of mTOR regulation in cancer","volume":"21","author":"Memmott","year":"2009","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0120","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/sj.onc.1207542","article-title":"Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression","volume":"23","author":"Fingar","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0125","first-page":"1","article-title":"PI3K\/AKT signaling pathway and cancer: an updated review","author":"Martini","year":"2014","journal-title":"Ann. Med."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pharmthera.2013.12.004","article-title":"Molecular targets for cancer therapy in the PI3K\/AKT\/mTOR pathway","volume":"142","author":"Polivka","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11523-011-0175-8","article-title":"Mammalian target of rapamycin as a target in hematological malignancies","volume":"6","author":"Kelly","year":"2011","journal-title":"Target. Oncol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0145","doi-asserted-by":"crossref","first-page":"12297","DOI":"10.1074\/jbc.M900573200","article-title":"ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy","volume":"284","author":"Ganley","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0150","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1089\/ars.2011.4396","article-title":"Regulation and function of uncoordinated-51 like kinase proteins","volume":"17","author":"Chan","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0155","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","article-title":"Regulation mechanisms and signaling pathways of autophagy","volume":"43","author":"He","year":"2009","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/BJ20101894","article-title":"The serine\/threonine kinase ULK1 is a target of multiple phosphorylation events","volume":"440","author":"Bach","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0165","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4161\/auto.28987","article-title":"ATG13: just a companion, or an executor of the autophagic program?","volume":"10","author":"Alers","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0170","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1091\/mbc.E08-12-1249","article-title":"ULK\u2013Atg13\u2013FIP200 complexes mediate mTOR signaling to the autophagy machinery","volume":"20","author":"Jung","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","article-title":"Autophagy and the integrated stress response","volume":"40","author":"Kroemer","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0180","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4161\/auto.7.7.15491","article-title":"ULK1 inhibits mTORC1 signaling, promotes multisite Raptor phosphorylation and hinders substrate binding","volume":"7","author":"Dunlop","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0185","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1517\/14728222.2012.694869","article-title":"Targeting the liver kinase B1\/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies","volume":"16","author":"Martelli","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0190","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1042\/BST20130030","article-title":"The kinase triad, AMPK, mTORC1 and ULK1, maintains energy and nutrient homoeostasis","volume":"41","author":"Dunlop","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0195","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2010.04.009","article-title":"Mitochondria supply membranes for autophagosome biogenesis during starvation","volume":"141","author":"Hailey","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0200","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ncb2078","article-title":"Plasma membrane contributes to the formation of pre-autophagosomal structures","volume":"12","author":"Ravikumar","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0205","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/ni.1720","article-title":"Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection","volume":"10","author":"English","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0210","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ceb.2010.01.001","article-title":"The Beclin 1 interactome","volume":"22","author":"He","year":"2010","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0215","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.febslet.2012.04.046","article-title":"Ubiquitination and phosphorylation of Beclin 1 and its binding partners: tuning class III phosphatidylinositol 3-kinase activity and tumor suppression","volume":"586","author":"Abrahamsen","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0220","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2005.07.002","article-title":"Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy","volume":"122","author":"Pattingre","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0225","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.biocel.2004.05.009","article-title":"LC3 conjugation system in mammalian autophagy","volume":"36","author":"Tanida","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0230","doi-asserted-by":"crossref","first-page":"47704","DOI":"10.1074\/jbc.M407016200","article-title":"Human light chain 3\/MAP1LC3B is cleaved at its carboxyl-terminal Met121 to expose Gly120 for lipidation and targeting to autophagosomal membranes","volume":"279","author":"Tanida","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0235","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ncb0910-836","article-title":"Selective autophagy: ubiquitin-mediated recognition and beyond","volume":"12","author":"Kraft","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0240","doi-asserted-by":"crossref","first-page":"424","DOI":"10.4161\/auto.22931","article-title":"Dissecting the role of the Atg12\u2013Atg5\u2013Atg16 complex during autophagosome formation","volume":"9","author":"Walczak","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0245","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1152\/physrev.00030.2009","article-title":"Regulation of mammalian autophagy in physiology and pathophysiology","volume":"90","author":"Ravikumar","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0250","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nrendo.2014.35","article-title":"Autophagy\u2014a key player in cellular and body metabolism","volume":"10","author":"Kim","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0255","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: an evolving paradigm for stem cell biology","volume":"132","author":"Orkin","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0260","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.bbamcr.2010.04.005","article-title":"The emerging role of the phosphatidylinositol 3-kinase\/Akt\/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis","volume":"1803","author":"Martelli","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0265","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/stem.1657","article-title":"Concise review: genetic dissection of hypoxia signaling pathways in normal and leukemic stem cells","volume":"32","author":"Gezer","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0270","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.cell.2008.10.048","article-title":"Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair","volume":"135","author":"Wilson","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jcp.21908","article-title":"The hematopoietic stem cell niche: low in oxygen but a nice place to be","volume":"222","author":"Eliasson","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0280","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4161\/auto.24132","article-title":"Autophagy in stem cells","volume":"9","author":"Guan","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00018-012-1032-3","article-title":"Tightrope act: autophagy in stem cell renewal, differentiation, proliferation, and aging","volume":"70","author":"Phadwal","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0290","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/emmm.201201999","article-title":"Autophagic control of cell \u2018stemness\u2019","volume":"5","author":"Pan","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0295","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1084\/jem.20101145","article-title":"The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance","volume":"208","author":"Mortensen","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0300","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1182\/blood-2010-06-288589","article-title":"FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells","volume":"116","author":"Liu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0305","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.4161\/auto.26681","article-title":"Mitophagy in hematopoietic stem cells: the case for exploration","volume":"9","author":"Joshi","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0310","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cell.2007.01.003","article-title":"FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress","volume":"128","author":"Tothova","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0315","doi-asserted-by":"crossref","first-page":"19384","DOI":"10.1073\/pnas.0810584105","article-title":"mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization","volume":"105","author":"Gan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0320","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","article-title":"The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche","volume":"7","author":"Simsek","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0325","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature11895","article-title":"FOXO3A directs a protective autophagy program in haematopoietic stem cells","volume":"494","author":"Warr","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0330","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.advenzreg.2011.10.002","article-title":"Regulation of autophagy by Forkhead box (FOX) O transcription factors","volume":"52","author":"van der Vos","year":"2012","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0335","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1126\/science.1182228","article-title":"Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies","volume":"327","author":"Lee","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0340","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2007.02.001","article-title":"Foxo3a is essential for maintenance of the hematopoietic stem cell pool","volume":"1","author":"Miyamoto","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0345","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1182\/blood-2008-05-159848","article-title":"FoxO3a regulates hematopoietic homeostasis through a negative feedback pathway in conditions of stress or aging","volume":"112","author":"Miyamoto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0350","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/cr.2011.200","article-title":"Autophagy is required for self-renewal and differentiation of adult human stem cells","volume":"22","author":"Salemi","year":"2012","journal-title":"Cell Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0355","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00214924","article-title":"Autophagy of mitochondria in rat bone marrow erythroid cells","volume":"239","author":"Heynen","year":"1985","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0360","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1073\/pnas.0913170107","article-title":"Loss of autophagy in erythroid cells leads to defective removal of mitochondria and severe anemia in vivo","volume":"107","author":"Mortensen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0365","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4161\/auto.24172","article-title":"Autophagy facilitates organelle clearance during differentiation of human erythroblasts: evidence for a role for ATG4 paralogs during autophagosome maturation","volume":"9","author":"Betin","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0370","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/MCB.06166-11","article-title":"Autophagy driven by a master regulator of hematopoiesis","volume":"32","author":"Kang","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0375","doi-asserted-by":"crossref","first-page":"19500","DOI":"10.1073\/pnas.0708818104","article-title":"NIX is required for programmed mitochondrial clearance during reticulocyte maturation","volume":"104","author":"Schweers","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20061303","article-title":"A critical role for the autophagy gene Atg5 in T cell survival and proliferation","volume":"204","author":"Pua","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0385","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4161\/auto.5.5.8133","article-title":"Identification of Atg5-dependent transcriptional changes and increases in mitochondrial mass in Atg5-deficient T lymphocytes","volume":"5","author":"Stephenson","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0390","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.4049\/jimmunol.0801143","article-title":"Autophagy is essential for mitochondrial clearance in mature T lymphocytes","volume":"182","author":"Pua","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0395","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1189\/jlb.0312123","article-title":"Transient receptor potential vanilloid 1 activation induces autophagy in thymocytes through ROS-regulated AMPK and Atg4C pathways","volume":"92","author":"Farfariello","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0400","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.4049\/jimmunol.1002223","article-title":"A role for autophagic protein beclin 1 early in lymphocyte development","volume":"186","author":"Arsov","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0405","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4161\/auto.5474","article-title":"The autophagy gene ATG5 plays an essential role in B lymphocyte development","volume":"4","author":"Miller","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0410","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1158\/1078-0432.CCR-07-5023","article-title":"The double-edged sword of autophagy modulation in cancer","volume":"15","author":"White","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0415","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1101\/gad.1545107","article-title":"Autophagy suppresses tumor progression by limiting chromosomal instability","volume":"21","author":"Mathew","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0420","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2009.03.048","article-title":"Autophagy suppresses tumorigenesis through elimination of p62","volume":"137","author":"Mathew","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0425","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1124\/mol.114.091850","article-title":"Autophagy and cancer therapy","volume":"85","author":"Thorburn","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0430","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.bbamcr.2009.01.006","article-title":"Anti- and pro-tumor functions of autophagy","volume":"1793","author":"Morselli","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0435","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00281-010-0213-0","article-title":"Autophagy and tumorigenesis","volume":"32","author":"Roy","year":"2010","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0440","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4161\/auto.6.3.11625","article-title":"Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer","volume":"6","author":"Dalby","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0445","article-title":"Therapeutic targeting of autophagy in cancer. Part II: pharmacological modulation of treatment-induced autophagy","author":"Nagelkerke","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0450","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4161\/auto.29428","article-title":"Outcome of early clinical trials of the combination of hydroxychloroquine with chemotherapy in cancer","volume":"10","author":"Poklepovic","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0455","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.4161\/auto.29264","article-title":"Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed\/refractory myeloma","volume":"10","author":"Vogl","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0460","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.semcancer.2013.05.006","article-title":"Autophagy in tumour cell death","volume":"23","author":"Macintosh","year":"2013","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2014.06.005","article-title":"Iron chelators induce autophagic cell death in multiple myeloma cells","author":"Pullarkat","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0470","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yexcr.2014.05.021","article-title":"Idarubicin induces mTOR-dependent cytotoxic autophagy in leukemic cells","volume":"326","author":"Ristic","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0475","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1038\/onc.2013.256","article-title":"A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy","volume":"33","author":"He","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcdb.2014.02.006","article-title":"Molecular mechanisms of regulated necrosis","author":"Galluzzi","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0485","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0490","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood-2011-04-347872","article-title":"Acute leukemia incidence and patient survival among children and adults in the United States, 2001\u20132007","volume":"119","author":"Dores","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0495","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/bjh.12750","article-title":"Prognostic factors for acute myeloid leukaemia in adults\u2014biological significance and clinical use","volume":"165","author":"Liersch","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0500","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0505","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1182\/blood.V96.13.4075","article-title":"Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group\/Eastern Cooperative Oncology Group Study","volume":"96","author":"Slovak","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0510","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12013-012-9392-8","article-title":"Blastic leukaemias (AML): a biologist's view","volume":"66","author":"Caceres-Cortes","year":"2013","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0515","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.1158\/0008-5472.CAN-05-0422","article-title":"Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation","volume":"65","author":"Brandts","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0520","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","article-title":"The roles of FLT3 in hematopoiesis and leukemia","volume":"100","author":"Gilliland","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0525","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMoa041974","article-title":"Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype","volume":"352","author":"Falini","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0530","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/85820","article-title":"Dominant-negative mutations of CEBPA, encoding CCAAT\/enhancer binding protein-\u03b1 (C\/EBP\u03b1), in acute myeloid leukemia","volume":"27","author":"Pabst","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0535","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.27896","article-title":"Myelodysplastic syndrome hematopoietic stem cell","volume":"133","author":"Li","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0540","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/07853890.2014.898863","article-title":"Myelodysplastic syndromes in the United States: an update for clinicians","volume":"46","author":"Troy","year":"2014","journal-title":"Ann. Med."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0545","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF02982641","article-title":"Oxidative stress and the myelodysplastic syndromes","volume":"77","author":"Farquhar","year":"2003","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0550","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/leu.2008.389","article-title":"Erythroid precursors from patients with low-risk myelodysplasia demonstrate ultrastructural features of enhanced autophagy of mitochondria","volume":"23","author":"Houwerzijl","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0555","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1172\/JCI34616","article-title":"PTEN posttranslational inactivation and hyperactivation of the PI3K\/Akt pathway sustain primary T cell leukemia viability","volume":"118","author":"Silva","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0560","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3892\/ijo.2014.2525","article-title":"Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia","volume":"45","author":"Evangelisti","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0565","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.leu.2404057","article-title":"Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients","volume":"20","author":"Nyakern","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0570","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1158\/0008-5472.CAN-06-4409","article-title":"The Akt\/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation","volume":"67","author":"Follo","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0575","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature04747","article-title":"PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention","volume":"441","author":"Zhang","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0580","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/blood-2008-10-187203","article-title":"Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome","volume":"114","author":"Mills","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0585","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/leu.2010.31","article-title":"Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells","volume":"24","author":"Pellagatti","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0590","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.4161\/cc.10.11.15673","article-title":"Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia","volume":"10","author":"Watson","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0595","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1517\/14656566.2013.794222","article-title":"5-Azacytidine for the treatment of myelodysplastic syndromes","volume":"14","author":"Krawczyk","year":"2013","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0600","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.4161\/cc.10.14.16308","article-title":"Azacitidine-resistant SKM1 myeloid cells are defective for AZA-induced mitochondrial apoptosis and autophagy","volume":"10","author":"Cluzeau","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0605","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.2174\/13816128113199990334","article-title":"How recent advances in high-risk myelodysplastic syndrome physiopathology may impact future treatments","volume":"19","author":"Cluzeau","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0610","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.4161\/auto.24921","article-title":"Dual inhibition of autophagy and the AKT pathway in prostate cancer","volume":"9","author":"Lamoureux","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0615","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4161\/auto.29119","article-title":"Combined mTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma","volume":"10","author":"Rangwala","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0620","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.4161\/auto.29231","article-title":"Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors","volume":"10","author":"Mahalingam","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0625","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1182\/blood-2006-12-061283","article-title":"Constitutive phosphoinositide 3-kinase\/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients","volume":"110","author":"Tamburini","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0630","doi-asserted-by":"crossref","first-page":"89","DOI":"10.18632\/oncotarget.114","article-title":"The phosphatidylinositol 3-kinase\/Akt\/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients","volume":"1","author":"Martelli","year":"2010","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0635","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.18632\/oncotarget.762","article-title":"A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia","volume":"3","author":"Chiarini","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0640","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1158\/1078-0432.CCR-13-3218","article-title":"Autophagy is a survival mechanism of acute myelogenous leukemia precursors during dual mTORC2\/mTORC1 targeting","volume":"20","author":"Altman","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0645","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/leu.2011.339","article-title":"The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia","volume":"26","author":"Willems","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0650","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1182\/blood-2013-03-493163","article-title":"Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia","volume":"122","author":"Willems","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0655","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood-2013-09-526392","article-title":"Asparaginase unveils glutamine-addicted AML","volume":"122","author":"Samudio","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0660","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1182\/blood-2011-09-378141","article-title":"Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process","volume":"119","author":"Rahmani","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0665","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1158\/1078-0432.CCR-10-0032","article-title":"The combination of a histone deacetylase inhibitor with the Bcl-2 homology domain-3 mimetic GX15-070 has synergistic antileukemia activity by activating both apoptosis and autophagy","volume":"16","author":"Wei","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0670","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2013-05-500629","article-title":"Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells","volume":"122","author":"Torgersen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0675","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood-2007-10-118810","article-title":"Treatment and prognostic impact of transient leukemia in neonates with Down syndrome","volume":"111","author":"Klusmann","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0680","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/leu.2013.264","article-title":"Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy","volume":"28","author":"Stankov","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0685","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1182\/blood-2008-08-173369","article-title":"The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies","volume":"113","author":"Nahimana","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0690","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00432-014-1640-4","article-title":"Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine-induced death of leukaemia cells","volume":"140","author":"Palmeira dos Santos","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0695","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/leu.2010.225","article-title":"HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells","volume":"25","author":"Liu","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0700","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.4161\/auto.32184","article-title":"HMGB1-dependent and -independent autophagy","volume":"10","author":"Sun","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0705","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","article-title":"Proposals for the classification of the acute leukaemias. French\u2013American\u2013British (FAB) co-operative group","volume":"33","author":"Bennett","year":"1976","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0710","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1126\/science.7079737","article-title":"Identification of the constant chromosome regions involved in human hematologic malignant disease","volume":"216","author":"Rowley","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0715","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/347558a0","article-title":"The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus","volume":"347","author":"de The","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0720","first-page":"802","article-title":"The retinoic acid receptor \u03b1 gene is rearranged in retinoic acid-sensitive promyelocytic leukemias","volume":"4","author":"Chomienne","year":"1990","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0725","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ccr.2007.06.006","article-title":"Recruitment of RXR by homotetrameric RAR\u03b1 fusion proteins is essential for transformation","volume":"12","author":"Zeisig","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0730","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrc2943","article-title":"Acute promyelocytic leukaemia: novel insights into the mechanisms of cure","volume":"10","author":"de The","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0735","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1158\/0008-5472.CAN-07-0972","article-title":"Mixed lineage leukemia translocations and a leukemia stem cell program","volume":"67","author":"Faber","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0740","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1084\/jem.20131121","article-title":"Synergy against PML-RAR\u03b1: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia","volume":"210","author":"Dos Santos","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0745","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1073\/pnas.0400053101","article-title":"All-trans retinoic acid\/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia","volume":"101","author":"Shen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0750","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1300874","article-title":"Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","author":"Lo-Coco","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2014.03.018","article-title":"Retinoid receptor signaling and autophagy in acute promyelocytic leukemia","volume":"324","author":"Orfali","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0760","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nm.1891","article-title":"Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation","volume":"14","author":"Nasr","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0765","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2010-01-261040","article-title":"Autophagy contributes to therapy-induced degradation of the PML\/RARA oncoprotein","volume":"116","author":"Isakson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0770","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4161\/auto.7.4.14397","article-title":"Autophagy regulates myeloid cell differentiation by p62\/SQSTM1-mediated degradation of PML-RARa oncoprotein","volume":"7","author":"Wang","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0775","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.4161\/auto.7.10.16623","article-title":"ATRA-induced upregulation of Beclin 1 prolongs the life span of differentiated acute promyelocytic leukemia cells","volume":"7","author":"Trocoli","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0780","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.4161\/auto.7.10.16636","article-title":"PML-RARa enhances constitutive autophagic activity through inhibiting the Akt\/mTOR pathway","volume":"7","author":"Huang","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0785","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood-2012-01-402578","article-title":"Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide","volume":"120","author":"Goussetis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0790","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/bph.12183","article-title":"Targeting survival pathways in chronic myeloid leukaemia stem cells","volume":"169","author":"Sinclair","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0795","doi-asserted-by":"crossref","first-page":"29989","DOI":"10.1074\/jbc.M109.090530","article-title":"Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide","volume":"285","author":"Goussetis","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0800","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bcp.2014.02.019","article-title":"Autophagy contributes to dasatinib-induced myeloid differentiation of human acute myeloid leukemia cells","volume":"89","author":"Xie","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0805","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","article-title":"Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?","volume":"120","author":"Pui","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0810","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0815","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1182\/asheducation.V2012.1.389.3798360","article-title":"The molecular genetic makeup of acute lymphoblastic leukemia","volume":"2012","author":"Mullighan","year":"2012","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0820","doi-asserted-by":"crossref","first-page":"e26348","DOI":"10.1371\/journal.pone.0026348","article-title":"The leukemia-specific fusion gene ETV6\/RUNX1 perturbs distinct key biological functions primarily by gene repression","volume":"6","author":"Fuka","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0825","doi-asserted-by":"crossref","first-page":"e80070","DOI":"10.1371\/journal.pone.0080070","article-title":"Differential effects of selective inhibitors targeting the PI3K\/AKT\/mTOR pathway in acute lymphoblastic leukemia","volume":"8","author":"Badura","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0830","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1038\/onc.2010.561","article-title":"Autophagy is essential to suppress cell stress and to allow BCR-Abl-mediated leukemogenesis","volume":"30","author":"Altman","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0835","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/leu.2011.84","article-title":"Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis","volume":"25","author":"Teuffel","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0840","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1440-1754.2011.02212.x","article-title":"Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia","volume":"48","author":"Bhadri","year":"2012","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0845","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/cdd.2009.46","article-title":"Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy","volume":"16","author":"Laane","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0850","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1038\/cddis.2010.53","article-title":"GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy","volume":"1","author":"Heidari","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0855","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood-2012-04-425033","article-title":"Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia","volume":"121","author":"Urtishak","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0860","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/leu.2013.226","article-title":"Targeting the PI3K\/Akt\/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential","volume":"28","author":"Neri","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0865","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/156800909787314057","article-title":"Emerging treatments in acute lymphoblastic leukemia","volume":"9","author":"Crazzolara","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0870","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4161\/auto.5.5.8507","article-title":"RAD001 (Everolimus) induces autophagy in acute lymphoblastic leukemia","volume":"5","author":"Crazzolara","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0875","doi-asserted-by":"crossref","first-page":"e102494","DOI":"10.1371\/journal.pone.0102494","article-title":"mTOR inhibition by everolimus in childhood acute lymphoblastic leukemia induces caspase-independent cell death","volume":"9","author":"Baraz","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0880","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4161\/auto.7.7.15154","article-title":"FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells","volume":"7","author":"Wallington-Beddoe","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0885","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bjh.12233","article-title":"Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis","volume":"161","author":"Teuffel","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0890","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.biocel.2014.04.015","article-title":"The epigenetic landscape of T-cell acute lymphoblastic leukemia","volume":"53","author":"Van der Meulen","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0895","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1172\/JCI61269","article-title":"The molecular basis of T cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0900","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nri2304","article-title":"Molecular pathogenesis of T-cell leukaemia and lymphoma","volume":"8","author":"Aifantis","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0905","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/leu.2013.63","article-title":"Novel TAL1 targets beyond protein-coding genes: identification of TAL1-regulated microRNAs in T-cell acute lymphoblastic leukemia","volume":"27","author":"Correia","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/leu.2011.151","article-title":"MicroRNAs in acute leukemia: from biological players to clinical contributors","volume":"26","author":"Schotte","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0915","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1365-2141.1997.2623081.x","article-title":"Inhibition of autophagy abrogates tumour necrosis factor \u03b1 induced apoptosis in human T-lymphoblastic leukaemic cells","volume":"98","author":"Jia","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0920","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1158\/0008-5472.CAN-10-1814","article-title":"Activity of the novel dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia","volume":"70","author":"Chiarini","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0925","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jcp.22407","article-title":"Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia","volume":"226","author":"Evangelisti","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0930","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1038\/leu.2012.136","article-title":"Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia","volume":"26","author":"Simioni","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0935","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/leu.2011.269","article-title":"AMP-dependent kinase\/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications","volume":"26","author":"Grimaldi","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0940","doi-asserted-by":"crossref","first-page":"e74768","DOI":"10.1371\/journal.pone.0074768","article-title":"C22:0- and C24:0-dihydroceramides confer mixed cytotoxicity in T-cell acute lymphoblastic leukemia cell lines","volume":"8","author":"Holliday","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0945","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1016\/j.febslet.2013.06.011","article-title":"ATF4 activation by the p38MAPK\u2013eIF4E axis mediates apoptosis and autophagy induced by selenite in Jurkat cells","volume":"587","author":"Jiang","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0950","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI39987","article-title":"Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance","volume":"120","author":"Bonapace","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0955","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.4161\/auto.28984","article-title":"A phase I\/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme","volume":"10","author":"Rosenfeld","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0960","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.4161\/auto.29118","article-title":"Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma","volume":"10","author":"Rangwala","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0965","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1078-0432.CCR-13-1978","article-title":"Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia","volume":"20","author":"Konopleva","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2014.09.023_bb0970","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.2011.08940.x","article-title":"Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)","volume":"156","author":"Amadori","year":"2012","journal-title":"Br. J. Haematol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488914003486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488914003486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T11:12:06Z","timestamp":1598353926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488914003486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":194,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0167488914003486"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2014.09.023","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autophagy in acute leukemias: A double-edged sword with important therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2014.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}